DOV
50
2
HPE
38
2
MS
70
6
AVY
47
3
PCG
66
5
DHI
29
2
TJX
54
6
HBI
56
3
CMA
46
3
IFF
47
3
DGX
29
2
EQIX
59
2
TEL
60
2
VRSK
59
5
DIS
72
4
THC
53
3
GD
44
2
GRMN
59
6
KO
46
4
WEC
41
2
DOV
50
2
HPE
38
2
MS
70
6
AVY
47
3
PCG
66
5
DHI
29
2
TJX
54
6
HBI
56
3
CMA
46
3
IFF
47
3
DGX
29
2
EQIX
59
2
TEL
60
2
VRSK
59
5
DIS
72
4
THC
53
3
GD
44
2
GRMN
59
6
KO
46
4
WEC
41
2
Financhill
Back

Universal Health Services Vs. Aligos Therapeutics Industry Stock Comparison

Buy
51

UHS
Universal Health Services

Last Price:
$180.39
Seasonality Move:
9.21%
Buy
62

ALGS
Aligos Therapeutics

Last Price:
$39.70
Seasonality Move:
7.18%
Buy
51
Universal Health Services (UHS) is a Buy

Is Universal Health Services a Buy, Sell or Hold?

  • The current Universal Health Services [UHS] share price is $181.22. The Score for UHS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • UHS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $39.34. The Score for ALGS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

UHS Stock Price Chart

What is Universal Health Services's stock price today?

  • The Universal Health Services share price today is $181.22
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UHS is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $39.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing selling pressure, which indicates risk of future bearish movement.

UHS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.8 Sell
Relative Strength Index (14 RSI): 32.91 Sell
Chaikin Money Flow: 126954 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (183.37 - 200.93) Sell
Bollinger Bands (100): (197.31 - 232.41) Sell

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.44 Buy
Relative Strength Index (14 RSI): 77.53 Buy
Chaikin Money Flow: -217768 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.98 - 35.56) Buy
Bollinger Bands (100): (6.92 - 24.5) Buy

UHS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 181.19 Buy
20-day SMA: 190.73 Sell
50-day SMA: 202.72 Sell
200-day SMA: 197.53 Sell
8-day EMA: 182.16 Sell
20-day EMA: 188.49 Sell
50-day EMA: 198.94 Sell
200-day EMA: 195.31 Sell

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.44 Buy
20-day SMA: 31.12 Buy
50-day SMA: 19.88 Buy
200-day SMA: 16.4 Buy
8-day EMA: 36.62 Buy
20-day EMA: 31.53 Buy
50-day EMA: 23.66 Buy
200-day EMA: 17.85 Buy

Universal Health Services Earnings Growth & UHS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.55 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.62 per share, and an increase next year of $2.24 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

Universal Health Services Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):